Metropolitan Life Insurance Company (MetLife)’s Colgate-Palmolive CL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,208	Closed	-$2.99M	–	431
2024 Q1	$2.99M	Sell	33,208 -307	-0.9%	-$26K	0.13%	139
2023 Q4	$2.67M	Sell	33,515 -689	-2%	-$51.8K	0.13%	142
2023 Q3	$2.43M	Sell	34,204 -1,947	-5%	-$146K	0.13%	142
2023 Q2	$2.79M	Sell	36,151 -1,205	-3%	-$93.3K	0.14%	135
2023 Q1	$2.81M	Sell	37,356 -9,872	-21%	-$734K	0.14%	129
2022 Q4	$3.72M	Sell	47,228 -2,430	-5%	-$182K	0.17%	120
2022 Q3	$3.49M	Sell	49,658 -812	-2%	-$63.7K	0.17%	122
2022 Q2	$4.04M	Sell	50,470 -1,543	-3%	-$121K	0.18%	114
2022 Q1	$3.94M	Sell	52,013 -64,820	-55%	-$5.13M	0.14%	138
2021 Q4	$9.97M	Sell	116,833 -2,153	-2%	-$168K	0.14%	116
2021 Q3	$8.99M	Sell	118,986 -4,230	-3%	-$336K	0.13%	124
2021 Q2	$10M	Buy	123,216 +19,596	+19%	+$1.6M	0.14%	114
2021 Q1	$8.17M	Sell	103,620 -6,083	-6%	-$477K	0.12%	143
2020 Q4	$9.38M	Sell	109,703 -5,883	-5%	-$486K	0.14%	121
2020 Q3	$8.92M	Sell	115,586 -5,061	-4%	-$386K	0.15%	118
2020 Q2	$8.84M	Sell	120,647 -7,537	-6%	-$535K	0.16%	110
2020 Q1	$8.51M	Sell	128,184 -495	-0.4%	-$34.9K	0.17%	107
2019 Q4	$8.86M	Buy	128,679 +476	+0.4%	+$32.5K	0.14%	129
2019 Q3	$9.42M	Sell	128,203 -7,794	-6%	-$565K	0.16%	113
2019 Q2	$9.75M	Buy	135,997 +8,638	+7%	+$613K	0.16%	106
2019 Q1	$8.73M	Sell	127,359 -5,247	-4%	-$339K	0.16%	109
2018 Q4	$7.89M	Sell	132,606 -805	-0.6%	-$50.4K	0.16%	109
2018 Q3	$8.93M	Sell	133,411 -5,128	-4%	-$342K	0.15%	116
2018 Q2	$8.98M	Sell	138,539 -2,552	-2%	-$167K	0.15%	124
2018 Q1	$10.1M	Buy	141,091 +464	+0.3%	+$33.4K	0.14%	108
2017 Q4	$10.6M	Sell	140,627 -281,711	-67%	-$20.6M	0.14%	101
2017 Q3	$30.8M	Sell	422,338 -8,704	-2%	-$627K	0.19%	89
2017 Q2	$32M	Sell	431,042 -11,677	-3%	-$867K	0.22%	83
2017 Q1	$32.4M	Sell	442,719 -9,462	-2%	-$662K	0.22%	81
2016 Q4	$29.6M	Sell	452,181 -12,837	-3%	-$880K	0.21%	86
2016 Q3	$34.5M	Sell	465,018 -4,526	-1%	-$335K	0.25%	72
2016 Q2	$34.4M	Sell	469,544 -34,773	-7%	-$2.48M	0.26%	70
2016 Q1	$35.6M	Sell	504,317 -10,357	-2%	-$689K	0.27%	65
2015 Q4	$34.3M	Sell	514,674 -7,968	-2%	-$530K	0.26%	71
2015 Q3	$33.2M	Buy	522,642 +17,081	+3%	+$1.12M	0.24%	79
2015 Q2	$33.1M	Sell	505,561 -1,061	-0.2%	-$72K	0.23%	85
2015 Q1	$35.1M	Sell	506,622 -8,398	-2%	-$580K	0.26%	81
2014 Q4	$35.6M	Sell	515,020 -2,691	-0.5%	-$182K	0.25%	81
2014 Q3	$33.8M	Sell	517,711 -14,188	-3%	-$936K	0.24%	85
2014 Q2	$36.3M	Sell	531,899 -31,633	-6%	-$2.12M	0.25%	80
2014 Q1	$36.6M	Sell	563,532 -11,861	-2%	-$747K	0.25%	76
2013 Q4	$37.5M	Sell	575,393 -12,279	-2%	-$786K	0.26%	77
2013 Q3	$34.8M	Sell	587,672 -1,961	-0.3%	-$116K	0.27%	71
2013 Q2	$33.8M	Buy	+589,633	New	+$35M	0.27%	69

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Colgate-Palmolive (CL) in Q2 2024, closing a stake of 33,208 shares — an estimated $2.99M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CL in Q2 2013 and held it in 44 quarters. The position peaked at $37.5M in Q4 2013. 1,820 funds tracked by Wall St. Rank hold CL as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Colgate-Palmolive position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 33,208 Colgate-Palmolive shares in Q2 2024, an estimated $2.99M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Colgate-Palmolive in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Colgate-Palmolive position peaked at $37.5M in Q4 2013.
1,820 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.